Analytical Data
-
Gene name
C9orf150
- Application
-
Alternative Names
LURAP1L; C9orf150; HYST0841; Leucine rich adaptor Protein 1-like
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8IV03
-
Expression Region
1-231aa
-
AA Sequence
MEDSPLPDLRDIELKLGRKVPESLVRSLRGEEPVPRERDRDPCGGSGGGGGGGGGGGGCSSGSSYCSFPPSLSSSSSSSPTSGSPRGSHSSALERLETKLHLLRQEMVNLRATDVRLMRQLLVINESIESIKWMIEEKATITSRGSSLSGSLCSLLESQSTSLRGSYNSLHDGSDGLDGISVGSYLDTLADDVPGHQTPSDLDQFSDSSLIEDSQALHKRPKLDSEYYCFG
-
Molecular Weight
51 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C9orf150, also known as a cancer-associated gene, has garnered significant attention in recent years due to its potential role in various biological processes, including cancer biology and immune response. The gene is located on chromosome 9 and is implicated in regulating cell proliferation and apoptosis. Recent studies have indicated that alterations in C9orf150 expression can influence tumorigenesis and the progression of several cancers, making it a target for therapeutic intervention. Researchers are focused on creating recombinant proteins of C9orf150 to elucidate its function and mechanism of action in cellular pathways. These studies involve cloning the gene, expressing it in suitable host systems, and assessing the resulting protein's structure and functional properties. By understanding how C9orf150 interacts with other cellular components, scientists hope to develop novel strategies for cancer diagnosis and treatment. Furthermore, exploring the role of C9orf150 in immune modulation could lead to advancements in immunotherapy, highlighting its importance in the field of cancer research. Overall, the investigation of C9orf150 recombinant proteins not only contributes to the fundamental understanding of cancer biology but also opens new avenues for targeted therapies.
